destiny breast 03 from #esmo21 presenter dr. erika hamilton
Published 2 years ago • 313 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
2:08
dr. erika hamilton discusses monarche at esmo20 for oncoalert
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
1:43
dr hamilton on implications of destiny-breast06 on the her2-low breast cancer paradigm
-
0:48
highlights from esmo: destiny-breast03
-
1:20
updated results of destiny-breast03: t-dxd vs t-dm1 in metastatic her2 breast cancer
-
19:46
metastatic breast cancer: what you need to know
-
8:47
what's new in breast cancer treatment in 2023 | top breast cancer docs discuss emerging research
-
5:11
destiny-breast04: t-dxd provides significant improvement in os pfs in her2-low mbc
-
1:26
is calcification in the breast a sign of breast cancer?
-
0:57
dr. erika p. hamilton on ont-380 in her2-positive breast cancer patients with brain metastases
-
3:21:26
the 2022 oncoalert colloquium day 1: breast cancer
-
1:07
dr. hamilton on the destiny-breast01 trial in her2 breast cancer
-
2:20
dr. matteo lambertini discusses impassion031 presented at #esmo20 with oncoalert
-
2:18
prostate cancer picks from #esmo21 from dr. axel merseburger
-
1:08
destiny-breast02: t-dxd in her2 metastatic breast cancer previously treated with t-dm1
-
2:08
destiny-breast07: t-dxd /- pertuzumab in patients with metastatic her2 breast cancer
-
3:05
esmo 2021: key trials for breast cancer
-
1:01
dr. hamilton discusses challenges with approved treatments for her2-positive breast cancer
-
1:57
dr. hamilton on phase 1 trial for her2 positive breast cancer - sarah cannon
-
2:48
destiny-breast03: t-dxd is superior to t-dm1 in her2 metastatic breast cancer
-
14:00
evaluating a treatment for her2-positive metastatic breast cancer
-
0:56
destiny-breast04: t-dxd for patients with her2-low mbc